These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1476754)

  • 21. A clinical and laboratory evaluation of the behavior of tissue polypeptide antigen in liver cirrhosis.
    Collazos J; Genollá J; Ruibal A
    Digestion; 1992; 53(3-4):157-61. PubMed ID: 1291404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CA 19-9 in non-neoplastic liver diseases. A clinical and laboratory study.
    Collazos J; Genolla J; Ruibal A
    Clin Chim Acta; 1992 Sep; 210(1-2):145-51. PubMed ID: 1424156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating CA 15-3 antigen levels in non-mammary malignancies.
    Colomer R; Ruibal A; Genollà J; Salvador L
    Br J Cancer; 1989 Feb; 59(2):283-6. PubMed ID: 2930693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The reliability of highly elevated CA 19-9 levels.
    Osswald BR; Klee FE; Wysocki S
    Dis Markers; 1993 Dec; 11(5-6):275-8. PubMed ID: 8082316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum secretory IgA and secretory component in patients with non-cirrhotic alcoholic liver diseases.
    Seillès E; Rossel M; Vuitton DA; Mercier M; Njoya O; Capron JP; Nalpas B; Gibey R; Revillard JP
    J Hepatol; 1995 Mar; 22(3):278-85. PubMed ID: 7608478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How does liver dysfunction influence serum CA 19-9 in pancreatic cancer?
    Basso D; Fabris C; Del Favero G; Piccoli A; Angonese C; Pasquali C; Castoro C; Plebani M; Leandro G; Burlina A
    Ital J Gastroenterol; 1990 Feb; 22(1):1-6. PubMed ID: 2131920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevation of serum and ascites cancer antigen 125 levels in patients with liver cirrhosis.
    Xiao WB; Liu YL
    J Gastroenterol Hepatol; 2003 Nov; 18(11):1315-6. PubMed ID: 14535990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of serum s-IgA detection in liver pathology (author's transl)].
    Thierry RC; Iscaki S; Pillot J
    Pathol Biol (Paris); 1979 Oct; 27(8):483-6. PubMed ID: 392419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non-cirrhotic alcoholic liver disease.
    Gonzàlez-Quintela A; Alende MR; Gamallo R; Gonzàlez-Gil P; López-Ben S; Tomé S; Otero E; Torre JA
    Hepatogastroenterology; 2003; 50(54):2121-6. PubMed ID: 14696478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [CA-125 in non-ovarian benign and malignant pathology: study on 380 patients].
    Marechal F; Berthiot G; Kritly T; Legrand MG; Deltour G; Cattan A
    Bull Cancer; 1989; 76(7):697-706. PubMed ID: 2819261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneous IgA glomerulonephropathy in liver cirrhosis.
    Sinniah R
    Histopathology; 1984 Nov; 8(6):947-62. PubMed ID: 6526391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Importance of the tumor-associated antigen CA 19-9 in the differential diagnosis of pancreatic diseases].
    Heptner G; Domschke S; Schneider MU; Domschke W
    Dtsch Med Wochenschr; 1985 Apr; 110(16):624-8. PubMed ID: 3857159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Behavior of the IgA, IgD, IgM immunoglobulins and transferrin in alcoholic hepatic disease].
    De Prado Isla LH; Artigas L
    Rev Clin Esp; 1973 Jun; 130(1):51-6. PubMed ID: 4755585
    [No Abstract]   [Full Text] [Related]  

  • 34. A new biomarker in monitoring breast cancer: CA 549.
    Beveridge RA; Chan DW; Bruzek D; Damron D; Bray KR; Gaur PK; Ettinger DS; Rock RC; Shurbaji MS; Kuhajda FP
    J Clin Oncol; 1988 Dec; 6(12):1815-21. PubMed ID: 3058875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased serum corrinoids correlates with disease severity and IgA levels in alcoholic cirrhosis.
    Djalali M; Champigneulle B; Guéant JL; el Kholty S; Gérard P; Nicolas JP
    Digestion; 1988; 41(4):215-22. PubMed ID: 3243381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serial measurements of Ca antigen in sera from patients with advanced malignant breast disease.
    Searle F; Chantler SM; Goodall AB; Adam T; Bagshawe KD; Mitchell HD; Boxer GM; Southall PM
    Clin Chim Acta; 1990 Jan; 186(3):351-8. PubMed ID: 2311260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum immunoglobulins and five serum proteins in extrahepatic obstructive jaundice and alcoholic cirrhosis. Immunoglobulins and proteins in liver diseases.
    LoGrippo GA; Anselm K; Hayashi H
    Am J Gastroenterol; 1971 Oct; 56(4):357-63. PubMed ID: 5117508
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tumor markers--personal experience. The use of tumor markers for cancer of digestive organs].
    Ishii M
    Gan To Kagaku Ryoho; 1991 May; 18(6):1059-65. PubMed ID: 1709347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease.
    Colomer R; Ruibal A; Salvador L
    Cancer; 1989 Oct; 64(8):1674-81. PubMed ID: 2790682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Glomerular IgA deposits in an autopsy study].
    Suganuma T
    Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):813-22. PubMed ID: 8072219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.